Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-1-6
pubmed:abstractText
The in vivo regulation of hematopoietic stem cell (HSC) function is poorly understood. Here, we show that hematopoietic repopulation can be augmented by administration of a glycogen synthase kinase-3 (GSK-3) inhibitor to recipient mice transplanted with mouse or human HSCs. GSK-3 inhibitor treatment improved neutrophil and megakaryocyte recovery, recipient survival and resulted in enhanced sustained long-term repopulation. The output of primitive Lin(-)c-Kit(+)Sca-1(+) cells and progenitors from HSCs increased upon GSK-3 inhibitor treatment without altering secondary repopulating ability, suggesting that the HSC pool is maintained while overall hematopoietic reconstitution is increased. GSK-3 inhibitors were found to modulate gene targets of Wnt, Hedgehog and Notch pathways in cells comprising the primitive hematopoietic compartment without affecting mature cells. Our study establishes GSK-3 as a specific in vivo modulator of HSC activity, and suggests that administration of GSK-3 inhibitors may provide a clinical means to directly enhance the repopulating capacity of transplanted HSCs.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1078-8956
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
89-98
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16341242-Animals, pubmed-meshheading:16341242-Blood Glucose, pubmed-meshheading:16341242-Cell Proliferation, pubmed-meshheading:16341242-Cell Transplantation, pubmed-meshheading:16341242-Cells, Cultured, pubmed-meshheading:16341242-Culture Media, Serum-Free, pubmed-meshheading:16341242-Enzyme Inhibitors, pubmed-meshheading:16341242-Fetal Blood, pubmed-meshheading:16341242-Flow Cytometry, pubmed-meshheading:16341242-Gene Expression Regulation, Enzymologic, pubmed-meshheading:16341242-Glycogen Synthase Kinase 3, pubmed-meshheading:16341242-Green Fluorescent Proteins, pubmed-meshheading:16341242-Hedgehog Proteins, pubmed-meshheading:16341242-Hematopoietic Stem Cells, pubmed-meshheading:16341242-Humans, pubmed-meshheading:16341242-Leukocytes, Mononuclear, pubmed-meshheading:16341242-Megakaryocytes, pubmed-meshheading:16341242-Mice, pubmed-meshheading:16341242-Mice, Inbred C57BL, pubmed-meshheading:16341242-Mice, SCID, pubmed-meshheading:16341242-Mice, Transgenic, pubmed-meshheading:16341242-Models, Biological, pubmed-meshheading:16341242-Neutrophils, pubmed-meshheading:16341242-Receptors, Notch, pubmed-meshheading:16341242-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16341242-Stem Cell Transplantation, pubmed-meshheading:16341242-Stem Cells, pubmed-meshheading:16341242-Time Factors, pubmed-meshheading:16341242-Trans-Activators, pubmed-meshheading:16341242-Wnt Proteins
pubmed:year
2006
pubmed:articleTitle
Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation.
pubmed:affiliation
Krembil Centre for Stem Cell Biology, Robarts Research Institute, 100 Perth Drive, London, Ontario, Canada, N6A 5K8.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural